195 related articles for article (PubMed ID: 12653859)
1. Levamisole and Chinese medicinal herbs can modulate the serum interleukin-6 level in patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2003 Apr; 32(4):206-14. PubMed ID: 12653859
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus.
Sun A; Chia JS; Chang YF; Chiang CP
J Oral Pathol Med; 2002 Apr; 31(4):196-203. PubMed ID: 12076322
[TBL] [Abstract][Full Text] [Related]
3. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
4. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of recurrent aphthous ulcerations.
Sun A; Chang YF; Chia JS; Chiang CP
J Oral Pathol Med; 2004 Mar; 33(3):133-9. PubMed ID: 15128054
[TBL] [Abstract][Full Text] [Related]
5. Levamisole and/or Chinese medicinal herbs can modulate the serum level of squamous cell carcinoma associated antigen in patients with erosive oral lichen planus.
Sun A; Chiang CP
J Oral Pathol Med; 2001 Oct; 30(9):542-8. PubMed ID: 11555157
[TBL] [Abstract][Full Text] [Related]
6. "Tien-Hsien liquid" can modulate antigen-stimulated cytokine production by T-cells isolated from patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Wang WB; Chiang CP
Am J Chin Med; 2005; 33(4):559-71. PubMed ID: 16173530
[TBL] [Abstract][Full Text] [Related]
7. Serum interleukin-8 level is a more sensitive marker than serum interleukin-6 level in monitoring the disease activity of oral lichen planus.
Sun A; Wang JT; Chia JS; Chiang CP
Br J Dermatol; 2005 Jun; 152(6):1187-92. PubMed ID: 15948980
[TBL] [Abstract][Full Text] [Related]
8. Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-alpha level in patients with mucocutaneous type of Behcet's disease.
Sun A; Wang YP; Chia JS; Liu BY; Chiang CP
J Oral Pathol Med; 2009 May; 38(5):401-5. PubMed ID: 19434815
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulation by levamisole in patients with recurrent aphthous ulcers or oral lichen planus.
Sun A; Chiang CP; Chiou PS; Wang JT; Liu BY; Wu YC
J Oral Pathol Med; 1994 Apr; 23(4):172-7. PubMed ID: 7913970
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategies for recurrent oral aphthous ulcers.
Barrons RW
Am J Health Syst Pharm; 2001 Jan; 58(1):41-50; quiz 51-3. PubMed ID: 11194135
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulating effects of "tien-hsien liquid" on peripheral blood mononuclear cells and T-lymphocytes from patients with recurrent aphthous ulcerations.
Sun A; Chia JS; Wang WB; Chiang CP
Am J Chin Med; 2004; 32(2):221-34. PubMed ID: 15315260
[TBL] [Abstract][Full Text] [Related]
12. Assessment of serum interleukin-8 as a sensitive serological marker in monitoring the therapeutic effect of levamisole in recurrent aphthous ulcers: a randomized control study.
Gupta P; Ashok L; Naik SR
Indian J Dent Res; 2014; 25(3):284-9. PubMed ID: 25098981
[TBL] [Abstract][Full Text] [Related]
13. Levamisole and low-dose prednisolone in the treatment of reccurent aphthous stomatitis.
Sharda N; Shashikanth MC; Kant P; Jain M
J Oral Pathol Med; 2014 Apr; 43(4):309-16. PubMed ID: 24822268
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2, interleukin-6 and T regulatory cells in peripheral blood of patients with Behçet's disease and recurrent aphthous ulcerations.
Pekiner FN; Aytugar E; Demirel GY; Borahan MO
J Oral Pathol Med; 2012 Jan; 41(1):73-9. PubMed ID: 21736625
[TBL] [Abstract][Full Text] [Related]
15. IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer.
Al-Samadi A; Kouri VP; Salem A; Ainola M; Kaivosoja E; Barreto G; Konttinen YT; Hietanen J; Häyrinen-Immonen R
J Oral Pathol Med; 2014 Feb; 43(2):117-24. PubMed ID: 23834281
[TBL] [Abstract][Full Text] [Related]
16. Response to levamisole and low-dose prednisolone in 41 patients with chronic oral ulcers: a 3-year open clinical trial and follow-up study.
Lu SY; Chen WJ; Eng HL
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Oct; 86(4):438-45. PubMed ID: 9798228
[TBL] [Abstract][Full Text] [Related]
17. Salivary IgA and IgG subclasses in oral mucosal diseases.
Sistig S; Vucićević-Boras V; Lukac J; Kusić Z
Oral Dis; 2002 Nov; 8(6):282-6. PubMed ID: 12477058
[TBL] [Abstract][Full Text] [Related]
18. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations.
Lewkowicz N; Lewkowicz P; Banasik M; Kurnatowska A; Tchórzewski H
Immunol Lett; 2005 Jun; 99(1):57-62. PubMed ID: 15894112
[TBL] [Abstract][Full Text] [Related]
19. [Clinical observation of the combined treatment of Chinese traditional medicine and levamisole for RAU].
Shang JZ; Zhang Y; Liu ZW
Shanghai Kou Qiang Yi Xue; 2010 Jun; 19(3):247-9. PubMed ID: 20635033
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticosteroids and oral medicine.
Pedersen A; Klausen B
J Oral Pathol; 1984 Feb; 13(1):1-15. PubMed ID: 6422017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
